WuXi Biologics (Cayman) Inc
F:1FW1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
WuXi Biologics (Cayman) Inc
F:1FW1
|
CN |
|
F
|
Franklin Resources Inc
SWB:FRK
|
US |
|
S
|
Sumitomo Mitsui Financial Group Inc
F:XMFA
|
JP |
|
Deutsche Post AG
MIL:DPW
|
DE |
|
L
|
Lincoln National Corp
F:LCO
|
US |
|
A
|
Activision Blizzard Inc
F:AIY
|
US |
|
New Oriental Education & Technology Group Inc
F:N1U0
|
CN |
|
O
|
ONEOK Inc
F:ONK
|
US |
|
C
|
Celanese Corp
XMUN:DG3
|
US |
|
F
|
FirstService Corp
F:1GIA
|
CA |
|
Kinsale Capital Group Inc
F:KCH
|
US |
|
A
|
AstraZeneca PLC
BMV:AZNN
|
UK |
|
I
|
Italgas SpA
F:I10
|
IT |
|
J
|
Jefferies Financial Group Inc
F:LN3
|
US |
|
Plexus Holdings PLC
LSE:POS
|
UK |
|
R
|
Resmed Inc
ASX:RMD
|
US |
|
Americold Realty Trust
NYSE:COLD
|
US |
|
Trillion Energy International Inc
F:Z620
|
CA |
|
FirstRand Ltd
F:FSRA
|
ZA |
|
B
|
Barclays PLC
SWB:BCY
|
UK |
|
Persimmon PLC
LSE:PSN
|
UK |
|
M
|
Mckesson Corp
XBER:MCK
|
US |
|
California Resources Corp
F:1CLD
|
US |
|
A
|
Atmos Energy Corp
F:AEO
|
US |
Wall St Price Targets
1FW1 Price Targets Summary
WuXi Biologics (Cayman) Inc
According to Wall Street analysts, the average 1-year price target for 1FW1 is 9.78 EUR with a low forecast of 6.48 EUR and a high forecast of 17.45 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1FW1's stock price target?
Price Target
9.78
EUR
According to Wall Street analysts, the average 1-year price target for 1FW1 is 9.78 EUR with a low forecast of 6.48 EUR and a high forecast of 17.45 EUR.
What is the Revenue forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
11%
Over the last 10 years, the compound annual growth rate for Revenue has been 44%. The projected CAGR for the next 8 years is 11%.
What is the Operating Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
15%
Over the last 10 years, the compound annual growth rate for Operating Income has been 61%. The projected CAGR for the next 8 years is 15%.
What is the Net Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
12%
Over the last 10 years, the compound annual growth rate for Net Income has been 60%. The projected CAGR for the next 8 years is 12%.
